Redox correlation in muscle lengthening and immune response in eccentric exercise

PLoS One. 2018 Dec 27;13(12):e0208799. doi: 10.1371/journal.pone.0208799. eCollection 2018.

Abstract

This study was designed to examine the potential involvement of reactive oxygen species in skeletal muscle dysfunction linked with stretching in a mouse model and to explore the effects of combined antioxidant intake on peripheral leukocyte apoptosis following eccentrically-biased downhill runs in human subjects. In the mouse model, diaphragmatic muscle was stretched by 30% of its optimal length, followed by 5-min contraction. Muscle function and extracellular reactive oxygen species release was measured ex vivo. In human models, participants performed two trials of downhill running either with or without antioxidant supplementation, followed by apoptotic assay of inflammatory cells in the blood. The results showed that stretch led to decreased muscle function and prominent ROS increase during muscle contraction. In human models, we observed an elevation in circulating leukocyte apoptosis 24-48 hours following acute downhill runs. However, there is an attenuated leukocyte apoptosis following the second bout of downhill run. Interestingly, the combination of ascorbic acid (vitamin C) and α-tocopherol (vitamin E) supplementation attenuated the decrease in B-cell lymphoma 2 (Bcl-2) at 24 hours following acute downhill running. These data collectively suggest that significant ROS formation can be induced by muscle-lengthening associated with eccentric exercise, which is accompanied by compromised muscle function. The combination of antioxidants supplementation appears to have a protective role via the attenuation of decrease in anti-apoptotic protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / immunology*
  • Ascorbic Acid / pharmacology
  • Leukocytes / immunology*
  • Leukocytes / pathology
  • Male
  • Mice
  • Muscle, Skeletal / immunology*
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / physiopathology
  • Muscular Diseases / immunology*
  • Muscular Diseases / pathology
  • Muscular Diseases / physiopathology
  • Oxidation-Reduction / drug effects
  • Physical Conditioning, Animal*
  • Proto-Oncogene Proteins c-bcl-2 / immunology
  • Reactive Oxygen Species / immunology*
  • Vitamin E / pharmacology

Substances

  • Antioxidants
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • Bcl2 protein, mouse
  • Vitamin E
  • Ascorbic Acid

Grants and funding

The human portion of this study was supported by Wastl Human Performance Laboratory, Donald L. Corrigan Professional Development Grant, Purdue Research Foundation, and Purdue University Bilsland Strategic Initiative Fellowship. The animal portion of this study was funded by The Ohio State University College of Medicine-Health and Rehabilitation Sciences Fund 013000 and American Physiology Society S&R Foundation Ryuji Ueno Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.